# Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic

> **NCT00553605** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 340 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Ketoprofen 100mg
- **DRUG:** Parecoxib 40mg

## Key facts

- **NCT ID:** NCT00553605
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2013-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553605, "Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00553605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*